Enfortumab vedotin induced interstitial lung disease: A first case report with pathological evidence from transbronchial lung cryobiopsy
Abstract
Enfortumab vedotin (EV), an antibody–drug conjugate targeting Nectin-4, has demonstrated efficacy against advanced urothelial carcinoma. While initially considered rare, EV-induced interstitial lung disease (ILD) is increasingly recognized, yet its pathological features remain poorly characterized. We report a case of a 60-year-old man with metastatic urothelial carcinoma who developed fever, fatigue, and cough after two cycles of EV therapy. His treatment history included right nephroureterectomy, platinum-based chemotherapy, and immune checkpoint inhibitors nivolumab and pembrolizumab. Laboratory tests revealed elevated serum ILD markers (Krebs von den Lungen-6527.7 U/mL, surfactant protein-D 294.5 ng/mL), and chest computed tomography showed new infiltrative shadows with air bronchogram predominantly in subpleural regions of the right lower lobe, consistent with organizing pneumonia pattern. Bronchoalveolar lavage from the right middle lobe showed 92 % macrophages with negative cultures. Transbronchial lung cryobiopsy revealed fibrosing nonspecific interstitial pneumonia with prominent fibrosis around bronchovascular bundles, lymphocytic infiltration in vessel walls and alveolar septa with myxofibrous thickening, epithelial injury, and fibrin exudation into alveolar spaces—representing previously undocumented features of EV-induced ILD. Drug discontinuation alone proved insufficient, but the patient improved markedly with methylprednisolone pulse therapy. This case…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.